Victoria Socha

DocwireNews

NKF 2021 Spring Clinical MeetingsOne part of clinical decision making focuses on an understanding of patient and physician preferences regarding various types of treatment. There are few data available examining the value patients and physicians place on specific treatment attributes in <a href="https://www.docwirenews.com/docwire-pick/epidemiology-and-burden-of-anemia-in-ckd-a-literature-review/">anemia</a> in chronic kidney disease. Ember (Yiwei) Lu, PharmD, and colleagues in the United States and the United Kingdom conducted a study to identify treatment attributes of value to patients and physicians and determine the relative importance of those attributes.Results of the discrete choice experiment (DCE) study were reported during a virtual poster session at the NKF Spring Clinical Meetings 2021. The <a href="https://casehippo.com/spa/symposium/national-kidney-foundation-2021-spring-clinical-meetings/event/gallery/abstracts?abstractId=1928">poster</a> was titled Patients&rsquo; and Physicians&rsquo; Preferences for Treatment of Anemia of Chronic Kidney Disease: Design Methods of a Discrete Choice Experiment.The study will include three phases. In phase one, evidence reviews and qualitative interviews were used to identify and describe relevant treatment attributes, supporting the understanding of the symptoms of anemia and their impact. In phase two, pilot interviews with patients and physicians will be used to test the design and validity of the DCE. In the third and final phase, the DCE will be conducted in the United States, Germany, and Japan in a cohort of non-dialysis-dependent and peritoneal dialysis patients, and physicians. A multinominal logit model will be used to analyze responses.The evidence review identified potential candidate attribute categories of benefit, risk, and convenience. Benefit attributes include items such as anemia symptom relief, number of required monthly blood transfusions, social and emotional impact, need for iron supplements, and life satisfaction/quality of life. Risk attributes include serious adverse events, lung damage, risk of major cardiovascular events, and geriatric complications. Convenience attributes include mode and frequency of administration, out-of-pocket costs, and product storage. The attributes will help inform the design of semi-structured interview guides that will be used in the qualitative interviews to further refine the final attribute list that will be used in collection of the main data.&ldquo;This study will address a crucial gap in renal disease research by quantifying, comparing, and contrasting treatment attributes that patients and physicians value. Knowledge of these attributes can benefit future shared decision making in clinical practice,&rdquo; the researchers said.Source: Lu E(Y), Okoro T, Amelio J, et al. Patients&rsquo; and physicians&rsquo; preferences for treatment of anemia in chronic kidney disease: Design methods of a discrete choice experiment. Abstract of a poster presented at the National Kidney Foundation virtual Spring Clinical Meetings 2021 (Abstract #169), April 9. 2021.

Jordana Jampel

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Infectious Disease

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Latest News

Treatment Preferences for Anemia in CKD

Anemia and Kidney Disease

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe